MCHPP vs NVDA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 09, 2026
MCHPP
57.8
AI Score
VS
MCHPP Wins
NVDA
44.3
AI Score
Investment Advisor Scores
NVDA
44score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | MCHPP | NVDA | Winner |
|---|---|---|---|
| Revenue | 1.48B | 177.84B | NVDA |
| Net Income | 229.80M | 118.01B | NVDA |
| Gross Margin | 63.2% | 75.0% | NVDA |
| Net Margin | 15.5% | 66.4% | NVDA |
| Operating Income | 336.80M | 117.27B | NVDA |
| ROE | 3.6% | 51.5% | NVDA |
| ROA | 1.6% | 36.8% | NVDA |
| Total Assets | 14.41B | 320.27B | NVDA |
| Cash | 272.30M | 22.44B | NVDA |
| Debt/Equity | 0.83 | 0.15 | NVDA |
| Current Ratio | 1.92 | 4.59 | NVDA |
Relative Price Performance (Last 90 Days)
MCHPP 1M: -6.5%
· 3M: -18.7%
NVDA 1M: -2.6%
· 3M: +6.6%
Current Technical Phase
MCHPP
NeutralHold
Mixed signals - no dominant trend phase, RSI 45
NVDA
NeutralHold
Mixed signals - no dominant trend phase, RSI 50
Fundamentals Snapshot
| Metric | MCHPP | NVDA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 27.8 |
| Trailing P/E | — | 28.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | 1.1% |
| Gross Margin | 0.6% | 0.7% |
| Operating Margin | 0.2% | 0.7% |
| EPS | 0.00 | 7.73 |
| Dividend Yield | 0.03% | 0.00% |
Frequently Asked Questions
Based on our detailed analysis, MCHPP is currently the stronger investment candidate based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.